Breaking News Instant updates and real-time market news.

LPCN

Lipocine

$4.60

-0.82 (-15.13%)

13:06
10/13/16
10/13
13:06
10/13/16
13:06

Lipocine drops after Clarus provides view on patent case against company

Shares of Lipocine (LPCN), an oral drug delivery technology company, are dropping after Clarus Therapeutics commented on its patent infringement lawsuit against Lipocine. WHAT'S NEW: On October 7, Lipocine announced that U.S. District Court in Delaware granted its motion to dismiss a lawsuit filed by Clarus Therapeutics. Clarus claimed that LPCN 1021 infringed Clarus' patent. LPCN 1021 is Lipocine's oral testosterone product candidate for testosterone replacement therapy, or TRT, in adult males for conditions associated with a deficiency or absence of endogenous testosterone, also known as hypogonadism. "We are pleased that the court has dismissed this lawsuit. Going forward, we will continue to aggressively defend our intellectual property," said Dr. Mahesh Patel, President and CEO of Lipocine. WHAT'S NOTABLE: Before the opening of trading this morning, Clarus Therapeutics commented on the prior ruling, noting that the court found that there was not an immediate reason to hear the case given Lipocine's failure to receive FDA market approval for LPCN 1021. Importantly, the decision was made without ruling on the validity of Clarus's U.S. Patent 8,828,428 and other merits of the case. Clarus CEO Dr. Robert Dudley said, "We remain strong in our belief that LPCN 1021 infringes Clarus's '428 patent and it is particularly noteworthy that the court did not rule on this central fact. If LPCN 1021 were to be approved by the FDA, our plan would be to vigorously pursue all avenues to keep Lipocine's LPCN 1021 from entering the market and protect the intellectual property, accompanying financial investment and years of work we have invested in JATENZO -- our oral TRT product." ANALYST VIEWS: Earlier this week, Canaccord analyst John Newman raised his price target on Lipocine to $15 from $6 as he said at the time that believes its oral testosterone product has better safety and convenience versus currently marketed gels and injectables. The analyst sees rapid market share gains and a 20% market share by 2024. Newman reiterated his Buy rating on Lipocine shares. Additionally, on October 7 H.C. Wainwright analyst Corey Davis started Lipocine with a Buy rating and $25 price target. PRICE ACTION: Shares of Lipocine are lower by 35c, or 7.6%, to $4.25 in afternoon trading.

LPCN Lipocine
$4.60

-0.82 (-15.13%)

06/30/16
ROTH
06/30/16
NO CHANGE
Target $30
ROTH
Buy
Lipocine price target lowered to $30 from $40 at Roth Capital
Roth Capital analyst Michael Higgins lowered his price target for Lipocine to $30 from $40 after the FDA issued a Complete Response Letter on Lipocine's oral testosterone product, LPCN 1021, citing "deficiencies related to the dosing algorithm." Roth Capital has a Buy rating on the shares.
10/07/16
HCWC
10/07/16
INITIATION
Target $25
HCWC
Buy
Lipocine initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Corey Davis started Lipocine with a Buy rating and $25 price target.
10/11/16
ADAM
10/11/16
NO CHANGE
Target $15
ADAM
Buy
Lipocine price target raised to $15 from $6 at Canaccord
Canaccord analyst John Newman raised his price target on Lipocine to $15 from $6 as he believes its oral testosterone product has better safety and convenience versus currently marketed gels and injectables. The analyst sees rapid market share gains and a 20% market share by 2024. Newman reiterated his Buy rating on Lipocine shares.

TODAY'S FREE FLY STORIES

DDAIF

Daimler AG

$72.82

-0.09 (-0.12%)

, PCAR

Paccar

09:50
06/23/17
06/23
09:50
06/23/17
09:50
Hot Stocks
EU commercial vehicle registrations up 9% in May »

In May, EU commercial…

DDAIF

Daimler AG

$72.82

-0.09 (-0.12%)

PCAR

Paccar

CNHI

CNH Industrial

$11.34

-0.1 (-0.87%)

NAV

Navistar

$25.37

-0.02 (-0.08%)

CMI

Cummins

$159.00

0.04 (0.03%)

ALSN

Allison Transmission

$37.25

0.06 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$59.51

-0.45 (-0.75%)

09:50
06/23/17
06/23
09:50
06/23/17
09:50
Options
Opening activity in Starbuck's expiring calls »

Opening activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

09:50
06/23/17
06/23
09:50
06/23/17
09:50
General news
Treasury Option Action: 10-year positioning »

Treasury Option Action:…

MITL

Mitel

$7.32

0.08 (1.11%)

09:49
06/23/17
06/23
09:49
06/23/17
09:49
Conference/Events
Mitel management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 29

    Aug

WHR

Whirlpool

$192.96

-2.2 (-1.13%)

09:48
06/23/17
06/23
09:48
06/23/17
09:48
Periodicals
Whirlpool refrigerator started deadly fire in Grenfell Tower, Bloomberg says »

A fire in London's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFM

Sprouts Farmers Market

$21.55

0.17 (0.80%)

09:47
06/23/17
06/23
09:47
06/23/17
09:47
Rumors
Rumor moving shares of Sprouts Farmers Market »

Rumor: Sprouts Farmers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
06/23/17
06/23
09:45
06/23/17
09:45
General news
New Home Sales to be reported at 10:00 »

May New Home Sales will…

GPMT

Granite Point Mortgage

09:44
06/23/17
06/23
09:44
06/23/17
09:44
Syndicate
Breaking Syndicate news story on Granite Point Mortgage »

Granite Point Mortgage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

GPMT

Granite Point Mortgage

09:43
06/23/17
06/23
09:43
06/23/17
09:43
Syndicate
Breaking Syndicate news story on Granite Point Mortgage »

Granite Point Mortgage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

MDSO

Medidata

$80.25

4.25 (5.59%)

09:42
06/23/17
06/23
09:42
06/23/17
09:42
Conference/Events
Medidata management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

  • 11

    Jul

LPI

Laredo Petroleum

09:41
06/23/17
06/23
09:41
06/23/17
09:41
Conference/Events
Laredo Petroleum management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

IFF

International Flavors

09:41
06/23/17
06/23
09:41
06/23/17
09:41
Hot Stocks
International Flavors to settle trade secret lawsuit with ZoomEssence for $56M »

ZoomEssence and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPMT

Granite Point Mortgage

09:40
06/23/17
06/23
09:40
06/23/17
09:40
Syndicate
Granite Point Mortgage indicated to open at $18-$19, IPO priced at $19.50 »

Granite Point Mortgage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

LGF.A

Lionsgate

09:40
06/23/17
06/23
09:40
06/23/17
09:40
Conference/Events
Lionsgate management to meet with B. Riley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

NGD

New Gold

, GILD

Gilead

$70.48

2.98 (4.41%)

09:40
06/23/17
06/23
09:40
06/23/17
09:40
Options
Unusually active option classes on open June 23rd »

Unusual total active…

NGD

New Gold

GILD

Gilead

$70.48

2.98 (4.41%)

ORCL

Oracle

VRX

Valeant

AMD

AMD

$14.38

0.4 (2.86%)

DIS

Disney

SLV

iShares Silver Trust

CAT

Caterpillar

COST

Costco

$159.79

-3.36 (-2.06%)

TWTR

Twitter

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 06

    Jul

  • 19

    Jul

  • 08

    Aug

  • 23

    Aug

  • 24

    Aug

  • 29

    Aug

STML

Stemline

$8.50

0.15 (1.80%)

09:39
06/23/17
06/23
09:39
06/23/17
09:39
Hot Stocks
Stemline presents updated stage 1 and 2 data from SL-401 trial »

Stemline Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 26

    Sep

LGF

Use LGF.A, LGF.B

09:39
06/23/17
06/23
09:39
06/23/17
09:39
Conference/Events
Use LGF.A, LGF.B management to meet with B. Riley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

INN

Summit Hotel Properties

09:38
06/23/17
06/23
09:38
06/23/17
09:38
Conference/Events
Summit Hotel Properties management to meet with Canaccord »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 13

    Jul

IMGN

ImmunoGen

$5.82

-0.2 (-3.32%)

09:38
06/23/17
06/23
09:38
06/23/17
09:38
Conference/Events
ImmunoGen management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

REGN

Regeneron

$526.53

4.51 (0.86%)

09:36
06/23/17
06/23
09:36
06/23/17
09:36
Hot Stocks
Breaking Hot Stocks news story on Regeneron »

Regeneron down 4.6% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$14.68

0.48 (3.38%)

09:36
06/23/17
06/23
09:36
06/23/17
09:36
Periodicals
Several private equity firms have reached out to Etsy, Dealreporter says »

While Etsy has not been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

09:36
06/23/17
06/23
09:36
06/23/17
09:36
Technical Analysis
Technical View: Caterpillar slips lower, analyst action »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HQY

HealthEquity

$51.05

-0.39 (-0.76%)

09:36
06/23/17
06/23
09:36
06/23/17
09:36
Conference/Events
HealthEquity management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

APLP

Archrock Partners LP

$13.66

0.61 (4.67%)

09:35
06/23/17
06/23
09:35
06/23/17
09:35
Downgrade
Archrock Partners LP rating change  »

Archrock Partners LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:35
06/23/17
06/23
09:35
06/23/17
09:35
General news
U.S. new home sales preview: »

U.S. new home sales…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.